Partners and Collaborations

UCL's Cancer Domain underpins UCL's cross-disciplinary approach to cancer research, bringing researchers together to advance our understanding of cancer and develop improved diagnostics and treatment.

UCL is a founding partner of The Crick. Its work explores why disease develops and find new ways to treat, diagnose and prevent illnesses such as cancer, improving patient care and saving lives.

UCL Partners - Europe's largest Academic Health Science Network - brings together more than 100,000 health professionals and academics, and more than six million patients.

Provides resources and infrastructure for drug development, early phase clinical trials and molecular pathology and diagnostics.

Early phase trials take place in a dedicated facility and jointly with the Sarah Canon Research Institute in London. This provides patients with greater access to novel therapeutic agents.

Part of a world-class network for the translation of cancer research for patient benefit, focussing on new treatments such as gene therapy, health behaviours and drug discovery.

One of the UK's largest and most advanced outpatient cancer care facilities, providing significant opportunities to recruit patients to clinical studies, and to recruit top clinician-scientists.

The Proton Beam Treatment Centre at UCLH will provide significant opportunities for clinical research in paediatric and deep-lying tumours, as well as advancing imaging research at UCL.

The Bill Lyons Informatics Centre is part of the UCL Cancer Institute. It is a hub of bioinformatics expertise for cancer genomics.